RxDx Device for non-small cell lung cancer has received Breakthrough Device Designation from the U.S. Food and Drug ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based ...

Oxford will become the first UK city to benefit from a new initiative using street lighting to provide improved mobile connectivity.

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based image analysis with a level ...

Between American Tower and Crown Castle, one offers stronger FFO growth, a stable dividend, and a better balance sheet. Find ...

The global non-small cell lung cancer market is on track for exceptional growth, driven by increasing demand for innovative treatment solutions. According to recent market projections, the market ...

Dyness, a global pioneering provider of energy storage solutions, is thrilled to announce its participation in Intersolar ...

Stem cells - also known as "multi-purpose" - are one of the most promising tools of regenerative medicine: they are ...

As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...

A groundbreaking new urine test could soon help spot the early warning signs of lung cancer long before symptoms appear.